Digital Well being Product Chief, Eitan Shay, joins Dario as Chief Product Officer

Digital Health Product Leader, Eitan Shay, joins Dario as Chief Product Officer

Dario additionally appoints digital veteran, Arnaud Robertto the function of strategic advisor to the CEO

The appointments strengthen Dario’s capacity to scale its digital therapeutics platform to satisfy rising market demand

NEW YORK, April 4, 2023 /PRNewswire/ — DarioHealth Corp . (Nasdaq: DRIO) (the “Firm” or “Dario”), a world market chief in digital therapies (DTx), at this time introduced that digital well being veteran, Eitan Shay, joins the corporate within the newly created place of Chief Product Officer. Mr. Shay beforehand held product management roles at digital well being firms Livongo and Teladoc Well being, in addition to senior management roles at Meta Platforms.

Dario additionally introduced at this time that the pinnacle of digital and enterprise transformation, Arnaud Roberthas joined as Strategic Advisor to Erez Raphael, Dario’s CEO. Mr. Robert most lately served as Government Vice President and Chief Digital Officer at Sanofi and beforehand labored at Viking Cruise Traces, Nike, Disney and Microsoft.

“Demand for our resolution continues to speed up amongst payers and employers, and the power to enhance and scale our clever platform is central to our progress technique,” mentioned Erez Raphael, CEO of Dario. “I could not be extra excited to welcome Eitan to the Dario crew as his distinctive background gives a mix of expertise in high-growth industrial product environments together with a deep understanding of client engagement. Steady innovation with a deal with engagement shall be key to our long-term success and I imagine Eitan is the best candidate to tackle this necessary function.”

“I’m additionally very glad about that Arnaud Robert will be a part of Dario as a strategic advisor. Having led digital technique and innovation at many flagship firms, together with Sanofi, Nike and Disney, his distinctive perspective and expertise will serve us properly and guarantee we stay on the forefront of the digital and data-driven transformation of healthcare.”

“Having labored in digital well being for the previous a number of years, I’m impressed with each the tempo and success of Dario’s transformation to grow to be a number one multi-chronic situation platform that gives a seamless and extremely partaking person expertise,” said Mr. Shay. “Client engagement by means of expertise continues to rework healthcare supply. I imagine Dario could be very properly positioned to be a pacesetter within the area and I look ahead to contributing to our future success.”

As well as, Dario introduced that the 3 April 2023, turned Mr. Shay granted a non-qualified inventory choice award to buy 100,000 shares of the Firm’s widespread inventory, in addition to a further non-qualified performance-based inventory choice award to buy a further 80,000 shares of the Firm’s widespread inventory. These choices are issued pursuant to Nasdaq Itemizing Rule 5635(c)(4) and are exterior the Firm’s present fairness compensation plans. These choices have been granted as an incentive to Mr. Shay was employed by the Firm in accordance with Nasdaq Itemizing Rule 5635(c)(4).

The choices have an train worth per share equivalent to $3.93which was the closing worth of the corporate’s widespread inventory on the Nasdaq Capital Market on 3 April 2023. The time-based choice vests over a three-year interval and is topic to a one-year cliff starting it 3 April 2023, topic to Mr. Shay’s continued employment with the Firm on the relevant vesting dates. The performance-based choice vests upon the achievement of non-public objectives, which shall be established inside 60 days of the grant date, topic to Mr. Shay’s continued employment with the Firm on the relevant vesting dates.

About DarioHealth Corp.

DarioHealth Corp. (Nasdaq: DRIO) is a number one digital remedy (DTx) firm revolutionizing how folks with continual situations handle their well being by means of a user-centric platform for multi-chronic situations. Our platform and suite of options ship customized and dynamic interventions powered by knowledge analytics and one-on-one teaching for diabetes, hypertension, weight administration, musculoskeletal ache and behavioral well being.

Our user-centric platform gives folks steady and tailor-made care for his or her well being, disrupting the normal episodic strategy to healthcare. This strategy empowers folks to holistically align their existence for sustainable habits change, resulting in distinctive person satisfaction, retention and outcomes, and making doing the fitting factor the straightforward factor to do.

Dario delivers its extremely user-rated options globally to well being plans and different payers, self-insured employers, care suppliers and shoppers. To be taught extra about Dario and its digital well being options, or for extra info, go to

Cautionary notice relating to forward-looking statements

This information launch and statements from representatives and companions of DarioHealth Corp. in reference to this, incorporates or could include forward-looking statements below the Personal Securities Litigation Reform Act of 1995. Statements that aren’t statements of historic reality could also be thought-about forward-looking statements. For instance, the Firm makes use of forward-looking statements on this press launch when it discusses that the appointments of Messrs. Shay and Robert strengthen Dario’s capacity to scale its digital therapeutics platform to satisfy rising market demand. With out limiting the generality of the foregoing, phrases comparable to “plan”, “challenge”, “potential”, “search”, “could”, “will”, “anticipate”, “imagine”, “anticipate”, “intend , ” “might”, “estimate” or “proceed” are supposed to establish forward-looking statements. Readers are cautioned that sure necessary elements could have an effect on the Firm’s precise outcomes and will trigger such outcomes to vary materially from any forward-looking statements which may be made on this press launch. Elements that will have an effect on the Firm’s outcomes embrace, however usually are not restricted to, regulatory approvals, product demand, market acceptance, impression of aggressive merchandise and pricing, product improvement, commercialization or technological difficulties, success or failure of negotiations and commerce, authorized, social and financial dangers and the dangers related to the adequacy of present liquidity sources. Extra elements that would trigger or contribute to variations between the corporate’s precise outcomes and forward-looking statements embrace, however usually are not restricted to, the dangers mentioned within the firm’s filings with the US Securities and Trade Fee. Readers are cautioned that precise outcomes (together with, with out limitation, the timing and outcomes of the Firm’s industrial and regulatory plans for Dario as described herein) could differ materially from these indicated within the forward-looking statements. The Firm undertakes no obligation to replace publicly any forward-looking statements, whether or not on account of new info, future occasions or in any other case, besides as required by relevant legislation.

DarioHealth Company Contact:
Mary Mooney
VP Advertising
[email protected]

Media contact:
Scott Stachowiak
[email protected]


SOURCE DarioHealth Corp.